Our mission is to help doctors in choosing the most effective treatment for patients with bone diseases. Currently, our main area of development is centered around cancerous bone conditions. Through the application of 3D printing, we recreate the patient's unique diseased bone condition in a laboratory environment, utilizing mineralized bone organoids. This enables us to assess different drug reactions and determine personalized treatment options. By surpassing the limitations of conventional animal and 2D models, we also envision our solution as a powerful tool for drug development, accurately reproducing human physiological conditions and driving innovation in the field. Looking ahead, our vision is to set the standard for personalized bone health care, making a significant impact on patient outcomes and treatment advancements.
